Skip to content

Flexion with the Journey II BCS Total Knee System. A Prospective, Non-randomized, Consecutive Series, Observational Study.

Flexion with the Journey II BCS Total Knee System. A Prospective, Non-randomized, Consecutive Series, Observational Study. - Flexion with the Journey II BCS Total Knee System

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40614
Enrollment
62
Registered
2014-03-05
Start date
2014-10-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cartilage damage osteoarthrosis

Interventions

Sponsors

Sint Maartenskliniek
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patient presents with non-inflammatory knee osteoarthritis (radiologically confirmed), requiring total knee arthroplasty • Patient is 40 to 70 years of age, inclusive • Patient plans to be available for follow-up through two years postoperative • Patient is in stable health and is free of or treated for cardiac, pulmonary, haematological, or other conditions that would pose excessive operative risk • Patient has

Exclusion criteria

Exclusion criteria: • Patient is known to have insufficient femoral or tibial bone stock • Patient has a BMI >35 • Patient*s expected physical activity after surgery is 2 or less on the UCLA Activity Scale • Patient has had previous hip or knee replacement surgery in the last 6 months • Patient is planned to have additional hip or contralateral knee replacement in the next 6 months • Patient has had major, non-arthroscopic surgery to the study knee, including osteotomy around the knee • Patient has an active, local infection or systemic infection • Patient has physical, emotional or neurological conditions that would compromise compliance with postoperative rehabilitation and follow-up • Patient has grade 3 collateral ligament insufficiency (complete tear of ligament) • Patient has knee flexion 10 degrees • Patient has rheumatoid arthritis, any autoimmune disorder or immunosuppressive disorder • Patient is pregnant or plans to become pregnant during course of study • Patient has a known sensitivity to materials in the device and/or cutting blocks • Patient has >30 degrees extension deficit

Design outcomes

Primary

MeasureTime frame
Maximal passive knee flexion measured on a lateral X-ray one year after surgery.

Secondary

MeasureTime frame
Clinical, functional and radiological performance as measured with: active flexion (lying and standing), KSS, EQ-5d, KOOS, Kujala, Forgotten Knee Score, VAS Satisfaction, number and type of Adverse Events, Hip-Knee-Ankle angle, Patellar tilt & displacement.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)